These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10632915)

  • 1. The effect of induced hypothermia on the duration of action of atracurium when given by infusion to critically ill children.
    Playfor SD; Thomas DA; Choonara I
    Paediatr Anaesth; 2000; 10(1):83-8. PubMed ID: 10632915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of action of atracurium when given by infusion to critically ill children.
    Playfor SD; Thomas DA; Choonara I
    Paediatr Anaesth; 2000; 10(1):77-81. PubMed ID: 10632914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
    Boyd AH; Eastwood NB; Parker CJ; Hunter JM
    Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and atracurium and laudanosine concentrations during a fixed continuous infusion of atracurium in mechanically ventilated patients with acute respiratory distress syndrome.
    Lefrant JY; Farenc C; De la Coussaye JE; Muller L; Ripart J; Cuvillon P; Saissi G; Eledjam JJ
    Anaesth Intensive Care; 2002 Aug; 30(4):422-7. PubMed ID: 12180578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients.
    Farenc C; Lefrant JY; Audran M; Bressolle F
    J Clin Pharmacol; 2001 Jan; 41(1):44-50. PubMed ID: 11144993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and dynamics of atracurium infusions after paediatric orthotopic liver transplantation.
    Chow B; Bowden MI; Ho E; Weatherley BC; Bion JF
    Br J Anaesth; 2000 Dec; 85(6):850-5. PubMed ID: 11732518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisatracurium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children.
    Withington D; Ménard G; Varin F
    Paediatr Anaesth; 2011 Mar; 21(3):341-6. PubMed ID: 21223452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective evaluation of the continuous infusion of cis-atracurium for neuromuscular blockade in the pediatric intensive care unit patient: efficacy and dosage requirements.
    Tobias JD
    Am J Ther; 1997; 4(9-10):287-90. PubMed ID: 10423621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cis-atracurium requirements during prolonged administration to a child.
    Tobias JD
    Can J Anaesth; 1997 Jan; 44(1):82-4. PubMed ID: 8988829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atracurium resistance in a critically Ill patient.
    Tschida SJ; Hoey LL; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):533-9. PubMed ID: 7479210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose requirements of continuous infusion of rocuronium and atracurium throughout orthotopic liver transplantation in humans.
    Weng XC; Zhou L; Fu YY; Zhu SM; He HL; Wu J
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):869-72. PubMed ID: 16130187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
    Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF
    Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inconsistency with train-of-four monitoring in a critically ill paralyzed patient.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):540-5. PubMed ID: 7479211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients.
    Pearson AJ; Harper NJ; Pollard BJ
    Intensive Care Med; 1996 Jul; 22(7):694-8. PubMed ID: 8844237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion.
    Grigore AM; Brusco L; Kuroda M; Koorn R
    Crit Care Med; 1998 Jan; 26(1):180-3. PubMed ID: 9428564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients.
    Smith CE; van Miert MM; Parker CJ; Hunter JM
    Anaesthesia; 1997 Sep; 52(9):833-41. PubMed ID: 9349062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of stabilization on the onset of neuromuscular block when assessed using accelerometry.
    Girling KJ; Mahajan RP
    Anesth Analg; 1996 Jun; 82(6):1257-60. PubMed ID: 8638801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mivacurium after atracurium in children.
    Goudsouzian NG; Denman W; Matta E
    Anesth Analg; 1994 Aug; 79(2):345-9. PubMed ID: 7639377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.
    Burmester M; Mok Q
    Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.